Search
BRD-810
go.drugbank.com/drugs/DB23607ExperimentalIt is an inhibitor of the protein myeloid cell leukemia 1 (MCL1). [A274263]
Levilimab
go.drugbank.com/drugs/DB16387InvestigationalLevilimab is under investigation in clinical trial NCT04227366 (Study of the Efficacy and Safety of BCD-089 in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis).
WX-UK1
go.drugbank.com/drugs/DB05476InvestigationalWX-UK1 is a 3-amidinophenylalanine-based non-cytotoxic small molecule that belongs to a new class of drugs. In animal models, WX-UK1 blocks tumor cell invasion, metastasis and primary tumor growth by inhibiting serine proteases and the u...
Imetelstat
go.drugbank.com/drugs/DB14909ApprovedInvestigational[A263973] It is used to treat anemia in patients with myelodysplastic syndromes (MDS), a group of hematologic disorders characterized by ineffective hematopoiesis, peripheral cytopenia, abnormal marrow
Iodide I-123
go.drugbank.com/drugs/DB09420ApprovedInvestigationalRadioactive I-123 in particular is effective for this use as its half-life of approximately 13.13 h (hours) is ideal for the 24-h (hour) iodine uptake test and it has a reduced radiation burden as compared
Reglitazar
go.drugbank.com/drugs/DB04971ExperimentalIt is the first non-thiazolidenedione to enter clinical trials.
Amonafide
go.drugbank.com/drugs/DB05022InvestigationalIt belongs to the families of drugs called topoisomerase inhibitors and intercalating agents.
Porphobilinogen
go.drugbank.com/drugs/DB02272ExperimentalIt is generated by the enzyme ALA dehydratase, and converted into hydroxymethyl bilane by the enzyme porphobilinogen deaminase.
N-acetyl-alpha-neuraminic acid
go.drugbank.com/drugs/DB03721Experimental(From Dorland, 28th ed, p1518)
Atigotatug
go.drugbank.com/drugs/DB14831InvestigationalIt is under investigation in clinical trial NCT02815592 (Trial of BMS-986012 in Combination With Platinum and Etoposide).
Synonyms: anti-[Fucosyl-GM1 (fucosylated monosialoganglioside 1)], Homo sapiens monoclonal antibody; H-gamma1 heavy chain Homo sapiens (1-452) [VH (Homo sapiens IGHV3-48*02 (90.7%) -(IGHD) -IGHJ3*01 (92.3%) M123>T